Growth Factor

Updated: 2026-09-15

Overview

Growth factors are signaling proteins that regulate cellular processes such as proliferation, differentiation, and survival. They bind to specific receptors on target cells, activating pathways critical for development and tissue repair. Common types include Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), and Transforming Growth Factor-beta (TGF-β). Originally discovered in the 1950s, growth factors are now pivotal in biopharmaceuticals, stem cell therapy, and cosmetic formulations. Their therapeutic potential spans from treating chronic wounds to combating cancer, though challenges like stability and delivery persist.

Physical and Chemical Properties

Growth factors are typically small proteins or glycoproteins with molecular weights ranging from 6 to 60 kDa. Their tertiary structure is crucial for receptor binding, making them sensitive to denaturation by heat or pH extremes. Most are supplied as lyophilized powders to extend shelf life. Solubility depends on the specific factor, but reconstitution in sterile buffers (e.g., PBS) is common. Stability varies; some require carriers like albumin to prevent adsorption to surfaces. Analytical techniques like SDS-PAGE and HPLC are used to verify purity and bioactivity.

Main Applications

In medicine, growth factors accelerate wound healing (e.g., PDGF in Regranex) and treat conditions like neutropenia (G-CSF). Research leverages them to cultivate stem cells or model diseases. The cosmetics industry incorporates EGF and FGF in anti-aging products. Industrial applications include bioprinting and cultured meat production, where growth factors stimulate tissue formation. However, costs and regulatory hurdles limit scalability. Innovations like recombinant technology aim to improve yield and reduce prices.

Safety and Storage

Handle growth factors with gloves and sterile tools to prevent contamination or degradation. Lyophilized forms are stable at -20°C for years, but reconstituted solutions often degrade within weeks even at 4°C. Avoid repeated freeze-thaw cycles. Safety data sheets (SDS) should be reviewed for specific hazards. Some growth factors (e.g., TGF-β) may pose carcinogenic risks. Disposal should follow biohazard protocols if derived from human or animal sources.

B2B Procurement Guide

Prioritize suppliers with ISO 13485 or GMP certifications for clinical-grade factors. Request certificates of analysis (CoA) detailing bioactivity (e.g., ED50), endotoxin levels (<1 EU/μg), and purity (>95%). Bulk purchases may negotiate 10–30% discounts. Consider recombinant vs. natural sources: recombinant E. coli-derived factors are cheaper but may lack post-translational modifications. For critical applications, mammalian cell-derived versions (e.g., CHO cells) offer higher fidelity but at 3–5x the cost.